Of note, our data suggest that the increase in serum p-tau species in ALS might be related to the elevation in p-tau and not to a general increase in t-tau levels, as t-tau concentrations in serum did not differ between ALS and disease controls in agreement with previous studies19,20. The gene discussed is MAPT; the disease is amyotrophic lateral sclerosis.